FDA Rule Stifles E-Cigarettes' Harm Reduction Role With Grandfather Date, Application Costs
This article was originally published in The Tan Sheet & The Rose Sheet
Executive Summary
Makers of e-cigarettes and other types of what FDA terms "electronic nicotine-delivery systems" look to Congress for help on allowing products already available when the agency published the rule to remain available without pre-market approval. However, litigation also has been filed against the rule.
You may also be interested in...
JAMA Study Finds E-Cigarettes, More Than NRTs, Help With Smoking Cessation During Pregnancy
As authors of JAMA study say theirs and others' research might influence regulatory policy on e-cigarettes’ use in smoking cessation, FDA publishes latest batch of warnings to businesses selling the products without pre-market approval required from the agency.
Will Novel NRT Interest Heat Up In US With First Clearance For ENDS Under Tobacco Control Act?
Without mentioning NRT space, FDA’s acceptance of one vape device and two replacement nicotine cartridges as tobacco products might reignite interest in proposals for ENDS or other novel products to be approved for smoking cessation claims. To gain clearance as tobacco products, the ENDS were shown to provide a benefit similar to efficacies required for an NRT.
Acetaminophen Dose Labeling, More Sunscreen Information Needed, House Appropriators Tell FDA
Appropriators are "concerned that the lack of dosing information" on OTC drugs for children ages six months to 2 years "may lead to dosing errors, adverse events and inadequate treatment of fever and pain.” They also ask USDA about fraud in its National Organic Program.